Business
Immune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer
Immune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer.
About this update from Biostax Corp.
[{"type":"text","content":"\n\n\n\nImmune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nImmune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer\nPR Newswire\nORLANDO, Fla. and DUBLIN, Ireland, Jan. 14, 2015\n\n\n\nORLANDO, Fla. and DUBLIN, Ireland, Jan. 14, 2015 /PRNewswire/ -- Immune Therapeutics Inc. (OTC:BB IMUN), a specialty pharmaceutical company involved in the manufacture, commercialization, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, today announced the appointment of Seth Elliot as President and Chief Operating Officer. \n\nAs part of the changes in management, Dr. Eugene Youkilis and Christopher Pearce have stepped down as officers of Immune Therapeutics but will continue to serve as members of the board of directors.  Christopher Pearce will also continue to serve as a director of Airmed Biopharma Limited and Sr. Vice President of TNI BioTech International, Ltd.   \n\nMs. Noreen Griffin, Chief Executive Officer of Immune Therapeutics, stated, \"We are very excited to bring on Mr. Elliott to the Company's management team. He brings tremendous operational, M & A, sales and marketing, and financial leadership to the table. The company believes that we can leverage his years of experience and expertise to move into sales, marketing and commercialization of our specialty pharmaceutical products. Mr. Elliott brings a proven track record, knowledge and relationships in the field of marketing, strategy and operational execution and will prove to be a strong asset to the company.\"\n\nSeth Elliott assumed the role as President and Chief Operating Officer on January 13, 2015. Mr. Elliot has spent more than 15 years as a founder or senior executive of emerging growth and middle market enterprises. He has helped to accelerate corporate growth in diverse markets, on behalf of a variety of companies through economic conditions ra...